About us
Team
History
Strategy, mission, values
Honors and awards
Education and CSR
Occupational Safety and Health
Partners
R&D
Products
Vaccines
Biotechnology products
Chemical products
Contract manufacture
Other products
Manufacturing
Biopharmaceuticals
Solid dosage forms
Quality control
Certificates
Press center
Company news
Company news
Photo gallery
Media kit
Media contacts
Photo gallery
Media kit
Media contacts
Careers
Vacancies
Vacancies
Corporate culture
Corporate culture
Contacts
Ещё
Ask a question
info@nanolek.ru
Moscow, Butyrsky Val, 68, bldg. 1 Baker Plaza Business Center, 2nd floor, office 24
Vkontakte
Facebook
Instagram
YouTube
EN
|
RU
About us
Team
History
Strategy, mission, values
Honors and awards
Education and CSR
Occupational Safety and Health
Partners
R&D
Products
Vaccines
Biotechnology products
Chemical products
Contract manufacture
Other products
Manufacturing
Biopharmaceuticals
Solid dosage forms
Quality control
Certificates
Press center
Company news
Photo gallery
Media kit
Media contacts
Careers
Vacancies
Corporate culture
Contacts
About us
Team
History
Strategy, mission, values
Honors and awards
Education and CSR
Occupational Safety and Health
Partners
R&D
Products
Vaccines
Biotechnology products
Chemical products
Contract manufacture
Other products
Manufacturing
Biopharmaceuticals
Solid dosage forms
Quality control
Certificates
Press center
Company news
Photo gallery
Media kit
Media contacts
Careers
Vacancies
Corporate culture
Contacts
EN
|
RU
About us
Back
About us
Team
History
Strategy, mission, values
Honors and awards
Education and CSR
Occupational Safety and Health
Partners
R&D
Products
Back
Products
Vaccines
Biotechnology products
Chemical products
Contract manufacture
Other products
Manufacturing
Back
Manufacturing
Biopharmaceuticals
Solid dosage forms
Quality control
Certificates
Press center
Back
Press center
Company news
Back
Company news
Company news
Photo gallery
Media kit
Media contacts
Photo gallery
Media kit
Media contacts
Careers
Back
Careers
Vacancies
Back
Vacancies
Vacancies
Corporate culture
Corporate culture
Contacts
info@nanolek.ru
Moscow, Butyrsky Val, 68, bldg. 1 Baker Plaza Business Center, 2nd floor, office 24
Vkontakte
Facebook
Instagram
YouTube
Press center
Press center
Company news
Positive results were obtained for the drug Brukinsa (Zanubrutinib) in a comparative trial with Ibrutinib
18.06.2021
Company news
The plant of Nanolek in Kirow Region is about to launch production of the third CoviVac vaccine
26.05.2021
Company news
Nanolek will invest 5 billion rubles in the full production cycle and proprietary vaccine development by 2024 to become a leader in Russia's vaccine market
19.05.2021
Company news
At a Meeting with Russian President Vladimir Putin on March 22, Nanolek Confirms Its Plans to Produce 5 Mln Doses of CoviVac Vaccine by the End of 2021
22.03.2021
Company news
Mikhail Nekrasov, CEO of NANOLEK, attends the XVI Annual Conference "Pharmaceutical Business in Russia"
15.03.2021
Company news
Maxim Stetsyuk, First Deputy General Director of Nanolek, takes part in the scientific conference on COVID-19
12.03.2021
Company news
NANOLEK continues to expand its portfolio of cancer drugs
11.03.2021
Company news
Participants of PHARMA'S COOL-2021 SKOLKOVO dig into GMP standards
05.03.2021
Company news
Marina Mazurevskaya, Deputy CEO for Legal Affairs and Government Relations Speaks at GR FORCE 2021 GR Director Forum
04.03.2021
Company news
Svetlana Zakirova, Deputy CEO for Development and Research at NANOLEK, delivered a speech at Pharma's cool in Skolkovo
03.03.2021
Company news
NANOLEK sums up the results for 2020
26.02.2021
Company news
NANOLEK and BeiGene: A Collaboration for Cancer Treatment in Russia
25.02.2021
Show more
1
2
3
4
5
...
15
All
Найти
